These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. So close, and yet so far away: The dichotomy of the specific immune response and inflammation in psoriasis and atopic dermatitis. Schäbitz A, Eyerich K, Garzorz-Stark N. J Intern Med; 2021 Jul; 290(1):27-39. PubMed ID: 33428274 [Abstract] [Full Text] [Related]
13. Systemic therapies in atopic dermatitis: The pipeline. Renert-Yuval Y, Guttman-Yassky E. Clin Dermatol; 2017 Jul; 35(4):387-397. PubMed ID: 28709570 [Abstract] [Full Text] [Related]
14. IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. Nograles KE, Zaba LC, Shemer A, Fuentes-Duculan J, Cardinale I, Kikuchi T, Ramon M, Bergman R, Krueger JG, Guttman-Yassky E. J Allergy Clin Immunol; 2009 Jun; 123(6):1244-52.e2. PubMed ID: 19439349 [Abstract] [Full Text] [Related]
15. Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets. Fujita H, Shemer A, Suárez-Fariñas M, Johnson-Huang LM, Tintle S, Cardinale I, Fuentes-Duculan J, Novitskaya I, Carucci JA, Krueger JG, Guttman-Yassky E. J Allergy Clin Immunol; 2011 Sep; 128(3):574-82.e1-12. PubMed ID: 21704361 [Abstract] [Full Text] [Related]
18. Expression of the T-helper 2-specific chemokine receptor CCR4 on CCR10-positive lymphocytes in atopic dermatitis skin but not in psoriasis skin. Vestergaard C, Deleuran M, Gesser B, Grønhøj Larsen C. Br J Dermatol; 2003 Sep; 149(3):457-63. PubMed ID: 14510975 [Abstract] [Full Text] [Related]
19. Pyridone 6, a pan-JAK inhibitor, ameliorates allergic skin inflammation of NC/Nga mice via suppression of Th2 and enhancement of Th17. Nakagawa R, Yoshida H, Asakawa M, Tamiya T, Inoue N, Morita R, Inoue H, Nakao A, Yoshimura A. J Immunol; 2011 Nov 01; 187(9):4611-20. PubMed ID: 21957150 [Abstract] [Full Text] [Related]